HeyJaredJulie Zhang
- Indexed articles, last 90 days
- 42
- Latest publication
- Sep 14, 2026
- Outlet visibility, for South China Morning Post
- Top 50K sites
- Earliest in this view
- Jul 8, 2026
Latest articles
Data from Greater Bay Area residents to help improve healthcare policy: GSK (opens the original)
Read excerpt
Executive says pharmaceutical company is investing in shared data infrastructure GSK Hong Kong and Macau general manager Nicholas Teo said patient data was very important because it could form “supplementary evidence” to support regulatory filings and potential label expansions, and also help to “discover benefits other than the medication itself”. Vaccines were one example, Teo said last week. While their effectiveness against target diseases such as flu, shingles and respiratory syncytial viru
Hong Kong targets biomedicine powerhouse status in debut 5-year plan (opens the original)
Read excerpt
Tied to the national strategy, the city’s first five-year blueprint doubles down on Greater Bay Area medical tech and healthcare cooperation Biomedicine is set to feature in Hong Kong’s first five-year plan, due to be unveiled next week, as the city’s top officials signal closer medical cooperation across the Greater Bay Area. Lending weight to those ambitions, global pharmaceutical company GSK emphasised its interest in expanding its role in the region’s biotech development on Wednesday, at the
As China embraces AI, only 24% of US pharma execs bet on it for drug-making (opens the original)
Read excerpt
Study finds 50 companies had fully, partially or planned to scale AI, tech which could slash drug discovery costs by US$26 billion globally “It’s only through that translation that companies can turn AI-driven speed into profit, and patients into real beneficiaries,” Yung added. Some 72 per cent of respondents said their companies were either “scaling” or had “fully scaled” AI across research and development, and no company reported having no plans to adopt the technology, the survey found. Yet
More Chinese developers of brain-computer interfaces move towards IPOs (opens the original)
Read excerpt
Arfysica and Neuracle aim for Star Market listings amid what a Morgan Stanley analyst calls the ‘early stage of a multi-year IPO upcycle’ BCIs aim to allow brain signals to control external devices, such as computers or robotic limbs. Elon Musk’s Neuralink is a prominent company developing the technology. Founded in 2015 with registered capital of 100 million yuan (US$15 million), Arfysica is controlled by founder Wang Wei, who holds a combined 51 per cent stake and serves as the company’s legal
China pumps massive US$54b into insurers, banks in financial powerhouse push (opens the original)
Read excerpt
The rare capital boost of such magnitude seeks to shore up insurers and banks as solvency pressures mount and regulatory demands loom The Ministry of Finance, which led the move, had rarely injected capital into financial institutions at such magnitude, according to analysts. China Life Insurance Company said it would receive 35 billion yuan to help strengthen its “ability to withstand risk”, according to its website. Among banks, the Agricultural Bank of China planned to raise up to 160 billion
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For South China Morning Post, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.